Envoy Medical, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q4 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Envoy Medical, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q4 2024.
Envoy Medical, Inc. Debt-to-equity for the quarter ending December 31, 2024 was -163 %, a 113% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q4 2024	-163	-86.6	-113%	Dec 31, 2024
Q3 2024	-182	-103	-132%	Sep 30, 2024
Q2 2024	-366	-302	-470%	Jun 30, 2024
Q1 2024	-128	-53.6	-71.6%	Mar 31, 2024
Q4 2023	-76.7	+16.7	+17.9%	Dec 31, 2023
Q3 2023	-78.5	+8.01	+9.26%	Sep 30, 2023
Q2 2023	-64.3	+30.1	+31.9%	Jun 30, 2023
Q1 2023	-74.8	+24.1	+24.3%	Mar 31, 2023
Q4 2022	-93.3	+7.79	+7.7%	Dec 31, 2022
Q3 2022	-86.5	+51.7	+37.4%	Sep 30, 2022
Q2 2022	-94.4			Jun 30, 2022
Q1 2022	-98.9			Mar 31, 2022
Q4 2021	-101			Dec 31, 2021
Q3 2021	-138			Sep 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.